Companies / BOC Sciences / Adecatumumab
BOC Sciences

Adecatumumab | BOC Sciences

Adecatumumab is a human IgG1 monoclonal antibody directed against the epithelial cell adhesion molecule (EpCAM). EpCAM is expressed in almost all adenocarcinomas and its activity is not dependent of K-Ras status. Adecatumumab acts as a drug candidate for the treatment of cancers.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.